Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/13/2025

Treatment of Klebsiella pneumoniae in Beta-Lactam Allergic Patients

Primary Recommendations

  • The Infectious Diseases Society of America recommends fluoroquinolones as the primary beta-lactam alternative for serious gram-negative infections, including Klebsiella species, in patients with beta-lactam allergy 1, 2, 3
  • For intra-abdominal infections with suspected multidrug-resistant organisms in beta-lactam allergic patients, the World Society of Emergency Surgery recommends amikacin 15-20 mg/kg daily in combination regimens 4

Alternative Therapies

  • The Centers for Disease Control and Prevention recommends a respiratory fluoroquinolone, such as levofloxacin 750 mg daily or moxifloxacin, as empiric therapy for respiratory tract infections in beta-lactam allergic patients 1, 2, 3
  • For severe or ICU infections, the Centers for Disease Control and Prevention recommends aztreonam plus a respiratory fluoroquinolone 2, 3

Important Considerations

  • The World Society of Emergency Surgery emphasizes the importance of clarifying the type of beta-lactam allergy and obtaining cultures and susceptibility testing immediately in beta-lactam allergic patients 4
  • The Infectious Diseases Society of America advises against using doxycycline as empiric monotherapy for suspected Klebsiella pneumonia in critically ill patients, due to common resistance and lack of guideline support 1